Results 141 to 150 of about 1,464,129 (347)

Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology [PDF]

, 2018
Christopher K. Bichakjian, Thomas Olencki, Sumaira Z. Aasi, Murad Alam, James Andersen, Rachel Blitzblau, Glen M. Bowen, Carlo M. Contreras, Gregory A. Daniels, Roy H. Decker, Jeffrey M. Farma, K.A. Fisher, Brian Gastman, Karthik Ghosh, Roy C. Grekin, Kenneth Grossman, Alan L. Ho, Karl D. Lewis, Manisha J. Loss, Daniel D. Lydiatt, Jane L. Messina, Kishwer S. Nehal, Paul Nghiem, Igor Puzanov, Chrysalyne D. Schmults, Ashok R. Shaha, Valencia D. Thomas, Yaohui G. Xu, John A. Zic, K Hoffmann, Anita M. Engh   +30 more
openalex   +1 more source

Supplementary Data from Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical Trials in Oncology: Prevalence, Associated Factors, and Implications

, 2023
Rifaquat Rahman, Geoffrey Fell, Steffen Ventz, Andrea Arfè, Alyssa M. Vanderbeek, Lorenzo Trippa, Brian M. Alexander   +6 more
openalex   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Focal Spot, Fall/Winter 1997 [PDF]

, 1997
https://digitalcommons.wustl.edu/focal_spot_archives/1077/thumbnail ...

core   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Focal Spot, Spring 1979 [PDF]

, 1979
https://digitalcommons.wustl.edu/focal_spot_archives/1023/thumbnail ...

core   +1 more source

Cancer Prevention and the American Society of Clinical Oncology [PDF]

, 2004
Scott M. Lippman, Bernard Levin, Dean E. Brenner, Gary Gordon, Carolyn Aldigé, Barnett S. Kramer, Judy E. Garber, Ernest T. Hawk, Patricia A. Ganz, Mark R. Somerfield   +9 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Performance of 18F-FDG PET/MRI and its parameters in staging and neoadjuvant therapy response evaluation in bladder cancer

iScience
Summary: 18F-FDG PET/MRI shows potential efficacy in the diagnosis of bladder cancer (BLCA). However, the performance of 18F-FDG PET/MRI in staging and neoadjuvant therapy (NAT) response evaluation for BLCA patients remains elusive. Here, we conduct this
Tianhang Li, Qinqin You, Shiwei Zhang, Rushuai Li, Shangxun Xie, Danyan Li, Shuyue Ai, Rong Yang, Hongqian Guo   +8 more
doaj   +1 more source

Clinical Pediatric Oncology [PDF]

Archives of Disease in Childhood, 1978
openaire   +2 more sources